By Dr. Luca Chiapperino delves into the implications of post-genomics on health and society, focusing on the molecularization of our biography, experiences, and living environment.
Covers the historical development of genomics, from Sanger sequencing to high-throughput technologies and cost reductions, highlighting the impact of key players like Craig Venter.
Focuses on large-scale inference for detecting QTL hotspots in sparse regression models, emphasizing the need to use genomics to understand variation in phenotypes and disease susceptibility.
Explores the impact of machine learning in understanding human diseases, focusing on historical significance, natural products discovery, and challenges in designer drugs.